BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Franken LC, Rassam F, van Lienden KP, Bennink RJ, Besselink MG, Busch OR, Erdmann JI, van Gulik TM, Olthof PB. Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma. BJS Open 2020;4:449-55. [PMID: 32181590 DOI: 10.1002/bjs5.50273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Benzing C, Haiden LM, Krenzien F, Mieg A, Wolfsberger A, Atik CF, Nevermann N, Fehrenbach U, Schöning W, Schmelzle M, Pratschke J. Textbook outcome after major hepatectomy for perihilar cholangiocarcinoma - definitions and influencing factors. Langenbecks Arch Surg 2022. [PMID: 35246771 DOI: 10.1007/s00423-022-02467-y] [Reference Citation Analysis]
2 Espersen C, Borgwardt L, Larsen PN, Andersen TB, Stenholt L, Petersen LJ. Nuclear imaging methods for the prediction of postoperative morbidity and mortality in patients undergoing localized, liver-directed treatments: a systematic review. EJNMMI Res 2020;10:101. [PMID: 32886289 DOI: 10.1186/s13550-020-00687-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Franken LC, Benzing C, Krenzien F, Schmelzle M, van Dieren S, Olthof PB, van Gulik TM, Pratschke J. Right-sided resection with standard or selective portal vein resection in patients with perihilar cholangiocarcinoma: a propensity score analysis. HPB (Oxford) 2021:S1365-182X(21)00611-0. [PMID: 34330643 DOI: 10.1016/j.hpb.2021.06.429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang X, Lan T, Zhong H, Zhang Z, Xie H, Li Y, Huang W. To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer. J Healthc Eng 2022;2022:8223336. [PMID: 35356619 DOI: 10.1155/2022/8223336] [Reference Citation Analysis]
5 van Keulen AM, Franssen S, van der Geest LG, de Boer MT, Coenraad M, van Driel LMJW, Erdmann JI, Haj Mohammad N, Heij L, Klümpen HJ, Tjwa E, Valkenburg-van Iersel L, Verheij J, Groot Koerkamp B, Olthof PB; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Nationwide treatment and outcomes of perihilar cholangiocarcinoma. Liver Int 2021;41:1945-53. [PMID: 33641214 DOI: 10.1111/liv.14856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 van Keulen AM, Buettner S, Besselink MG, Busch OR, van Gulik TM, IJzermans JNM, de Jonge J, Polak WG, Swijnenburg RJ, Erdmann JI, Groot Koerkamp B, Olthof PB. Primary and secondary liver failure after major liver resection for perihilar cholangiocarcinoma. Surgery 2021:S0039-6060(21)00338-X. [PMID: 34020794 DOI: 10.1016/j.surg.2021.04.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]